What if you'd held GRCE?
A $1,000 investment in Grace Therapeutics, Inc. (GRCE) at the month-end close of 2012-02 would be worth $2.65 at the close of 2026-09 — -99.7% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $7,351.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2012
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2012 | $1,000 | — |
| 2013 | $581 | -41.9% |
| 2014 | $233 | -60.0% |
| 2015 | $119 | -49.0% |
| 2016 | $58.14 | -51.0% |
| 2017 | $43.72 | -24.8% |
| 2018 | $38.60 | -11.7% |
| 2019 | $114 | +195.2% |
| 2020 | $15.35 | -86.5% |
| 2021 | $7.33 | -52.3% |
| 2022 | $2.91 | -60.3% |
| 2023 | $2.80 | -3.7% |
| 2024 | $3.62 | +29.4% |
| 2025 | $3.35 | -7.5% |
| 2026 | $2.03 | -39.3% |
Best and worst month-end to buy
The best single month-end close to have bought GRCE was 2023-08 ($2.06): $1,000 then is $1,019 today. The worst was 2013-07 ($1,934): $1,000 then is $1.09.
FAQ
What would $1,000 in GRCE be worth today?
A $1,000 investment in Grace Therapeutics, Inc. (GRCE) at the start of 2012 would be worth about $2.65 today, a total return of -99.7%. Dividends are reinvested in these figures.
What were the best and worst years for GRCE?
Grace Therapeutics, Inc. (GRCE)'s strongest calendar year since 2012 was 2019, a +195.2% return — $1,000 held through that year became about $2,952 by year-end. Its weakest year was 2020, at -86.5%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in GRCE have grown?
Investing $100 at the end of every month since 2012-02 would have grown to about $4,422 on $17,600 invested.
Did GRCE beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $7,351. GRCE trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Grace Therapeutics, Inc. (GRCE) historical total-return data from 2012-02 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.